Presently, BPC 157 therapy has still limited but encouraging clinical evidence (no toxicity in clinical trials (i.e., effective in ulcerative colitis, phase II) and toxicology studies without lethal dose (LD1)), and much more should be further achieved [1,2,3,4,5,6,7,8,9,10,11]
Undermethylation may represent one contributing or modifying pattern in a subgroup of patients
59% Increased sleep Within 130 minutes of administration 97% Relief of symptoms Opioid withdrawal (107 patients) 86% Pain reduction Patients with chronic pain (6/7) Dog of DL50 Security Profile No lethal dose ever determined 9 amino acids Nonapeptide WAGGDASGE Sequence How does the DSIP work
International Journal of Molecular Sciences , 19 (7), 1987
For purity documentation, please review our Certificates of Analysis and related details on third-party tested research peptides
Follicle Size Enlargement In animal studies, treatment has been shown to enlarge hair follicle size essentially pushing vellus (fine) hairs toward terminal (thick) hairs